ACR适宜性标准®卵巢癌筛查:2024年更新
本文总结随机对照试验和观察性试验数据,评估影像学在平均风险和高风险人群卵巢癌筛查中的作用。平均风险人群盆腔超声筛查证据不足,随机对照试验未显示死亡率获益;高风险特定人群盆腔超声筛查可能适当,但缺乏大型随机试验数据。
要点
- 平均风险人群不推荐卵巢癌筛查,随机对照试验未显示死亡率获益。
- 高风险特定人群盆腔超声筛查可能适当,但现有数据有限。
- 指南基于GRADE和RAND/UCLA适宜性方法,由多学科专家小组年度审查。
核心结论
- 平均风险人群盆腔超声筛查证据不足,随机对照试验未显示死亡率获益;高风险特定人群筛查可能适当,但缺乏大型随机试验数据。
研究设计与样本
- 指南基于对随机对照试验和观察性试验的文献综述,采用GRADE和RAND/UCLA适宜性方法,由多学科专家小组年度审查。
诊断标准与关键数值
- 平均风险人群:现有发表证据不足以推荐卵巢癌筛查。
- 高风险特定人群:盆腔超声筛查可能适当,但现有数据有限。
临床应用与阅片要点
- 平均风险人群不推荐卵巢癌筛查,依据随机对照试验未显示死亡率获益。
- 高风险特定人群盆腔超声筛查可能适当,需注意现有数据有限。
局限性
- 平均风险人群筛查证据不足,随机对照试验未显示死亡率获益。
- 高风险人群筛查数据有限,缺乏大型随机试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Ovarian cancer remains low in prevalence but has the highest mortality of all gynecologic malignancies. Population-based screening for ovarian cancer remains a topic of interest in contemporary practice, given that the majority of cancers encountered are high-grade aggressive malignancies, for which favorable survival is encountered in the setting of early-stage disease. This document summarizes a review of the available data from randomized and observational trials that have evaluated the role of imaging for ovarian cancer screening in average-risk and high-risk patients. When considering screening using pelvic ultrasound in average-risk patients, we found insufficient published evidence to recommend ovarian cancer screening. Randomized controlled trials have not demonstrated a mortality benefit in this setting. Screening with pelvic ultrasound may be appropriate for select patients at high risk, although the existing data remain limited as large, randomized trials have not been performed in this setting. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.
引用
- Venkatesan AM, Kilcoyne A, Akin EA, et al. ACR Appropriateness Criteria® Ovarian Cancer Screening: 2024 Update. J Am Coll Radiol. 2025. PMID: 40409887. doi:10.1016/j.jacr.2025.02.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。